Alpha Cognition (ACOG) Total Non-Current Liabilities (2023 - 2026)
Alpha Cognition (ACOG) posted quarterly Total Non-Current Liabilities of $17.2 million for Q4 2025, up 48.65% year-over-year from $11.5 million in Q4 2024, and up 11.7% quarter-over-quarter from $15.4 million in Q3 2025.
Alpha Cognition (ACOG) Total Non-Current Liabilities (2023 - 2026) Analysis & Trends
Alpha Cognition's Total Non-Current Liabilities history runs 3 years deep, the most recent figure standing at $17.2 million for Q4 2025.
- In Q4 2025, Total Non-Current Liabilities rose 48.65% year-over-year to $17.2 million; the TTM figure through Dec 2025 stood at $17.2 million (up 48.65% YoY), while the FY2025 annual figure was $17.2 million, up 48.65% from the prior year.
- Total Non-Current Liabilities for Q4 2025 stood at $17.2 million, up from $15.4 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $17.2 million in Q4 2025, with the low at $2.5 million in Q2 2024.
- The 3-year median for Total Non-Current Liabilities is $7.4 million (2023), against an average of $9.0 million.
- Peak annual rise in Total Non-Current Liabilities reached 179.3% in 2025, while the deepest fall reached 48.65% in 2025.
- Alpha Cognition's Total Non-Current Liabilities stood at $7.1 million in 2023, then jumped by 63.18% to $11.5 million in 2024, then surged by 48.65% to $17.2 million in 2025.
- Business Quant data shows ACOG's Total Non-Current Liabilities at $17.2 million in Q4 2025, $15.4 million in Q3 2025, and $5.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn | 5.92 Bn |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.54 Bn | 3.93 Bn | 7.74 Bn |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn | 40.00 Mn |
| 4 | Moderna | 59.41 Bn | 54.27 Bn | 52.00 Mn | 3.92 Bn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 1.88 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn | 724.15 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 1.17 Bn |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - | 9.32 Bn |
| 10 | Alpha Cognition | 206.42 Mn | 164.98 Mn | 5.70 Mn | 6.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.48 Mn |
| Dec 31, 2025 | 17.15 Mn |
| Sep 30, 2025 | 15.36 Mn |
| Jun 30, 2025 | 4.99 Mn |
| Mar 31, 2025 | 7.71 Mn |
| Dec 31, 2024 | 11.54 Mn |
| Sep 30, 2024 | 5.50 Mn |
| Jun 30, 2024 | 2.53 Mn |
| Dec 31, 2023 | 7.07 Mn |